Taoyuan, Taiwan

Ming-Hsi Chiou

This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent. Top assignee: Optimer Pharmaceuticals, Inc.. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ming-Hsi Chiou. Retrieved from https://idiyas.com/inventor/ming-hsi-chiou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Ming-Hsi Chiou: Pioneering Tiacumicin Production

Introduction: Ming-Hsi Chiou, a prominent inventor based in Taoyuan, Taiwan, has made significant contributions to the field of biotechnology with his innovative work on Tiacumicin production. His dedication to advancing microbial cultivation techniques has positioned him as a key player in pharmaceutical research and development.

Latest Patents: Ming-Hsi Chiou holds a notable patent for the production of Tiacumicins. This patent focuses on methods, processes, and materials for producing and recovering Tiacumicins from microorganisms that possess the ability to produce and accumulate these compounds in a nutrient-rich medium. Notably, his invention utilizes fish powder as a nitrogen source and achieves a yield greater than approximately 50 mg/L of broth.

Career Highlights: Chiou's professional journey is marked by his association with Optimer Pharmaceuticals, Inc., where he has applied his expertise to the development of innovative pharmaceutical products. His work has contributed significantly to the company's research endeavors and has paved the way for advancements in antibiotic therapies.

Collaborations: Throughout his career, Ming-Hsi Chiou has collaborated with esteemed colleagues, including Youe-Kong Shue and Chi-Jen Frank Du. These partnerships have been instrumental in fostering a collaborative environment that encourages innovative thinking and the exchange of ideas within the realm of biotechnology.

Conclusion: Ming-Hsi Chiou continues to be a driving force in the field of microbial biotechnology with his pioneering research on Tiacumicin production. As he collaborates with other experts in the industry, his work reflects a commitment to enhancing pharmaceutical innovation and improving therapeutic solutions for various medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…